Effects and mechanism of oridonin on pulmonary hypertension induced by chronic hypoxia-hypercapnia in rats
- Author:
- No author available
- Journal Title:
- CHINESE MEDICAL JOURNAL
- Issue:
- 12
- DOI:
- 10.3760/cma.j.issn.0366-6999.2009.12.005
- Key Word:
- oridonin;hypoxia-hypercapni;apoptosis;mitochondria;pulmonary hypertension
Abstract： Background Pulmonary arterial hypertension (PAH) is characterized by suppressing apoptosis and enhancing cell proliferation in the vascular wall. Inducing pulmonary artery smooth muscle cells (PASMC) apoptosis had been regarded as a therapeutic approach for PAH. Oridonin can cause apoptosis in many cell lines, while little has been done to evaluate its effect on PASMC.Methods Thirty male Sprague-Dawley rats were randomly assigned to three groups: normal control (NC); hypoxia-hypercapnia (HH); Hypoxia-hypercapnia + oridonin (HHO). Flats were exposed to hypoxia-hypercapnia for four weeks. Cultured human PASMC (HPASMC) were assigned to three groups: normoxia (NO); hypoxia (HY); hypoxia+ oridonin (HO). The mean pulmonary artery pressure, mass ratio of right ventricle over left ventricle plus septum (RV/(LV+S)), the ratio of thickness of the pulmonary arteriole wall to vascular external diameter (WT%) and the ratio of the vessel wall area to the total area (WA%) were measured. Morphologic changes of pulmonary arteries were observed under light and electron microscopes. The apoptotic characteristics in vitro and in vivo were detected. Results The mPAP, RV/(LV+S), WT%, and WA% in the HH group were significantly greater than those in the NC (P <0.01) and HHO groups (P <0.01); the activities of caspase-3 and caspase-9, and the expressions of Bex, cyt-C and apoptotic index (AI) in the group HH were less than those in the NC and HHO groups; and the expression of Bcl-2 in group HH was greater than that in the NC and HHO groups. HPASMC mitochondrial membrane potentials in group HO was lower than in group HY (P <0.01), and cyt-C in the cytoplasm, AI, and caspase-9 in the HO group were greater than that in the HY group (P <0.01), but the expression of Bcl-2 in the HO group was less than that in the HY group (P <0.05). Conclusions The results suggest that oridonin can lower pulmonary artery pressure effectively, and inhibit pulmonary artery structural remodeling by inducing smooth cell apoptosis via a mitochondria-dependent pathway.
- [1]Mainali prabha,JIN Hong-fang,TIAN Yue,etc.Mechanisms responsible for pulmonary hypertension[J].2008,(24).
- [2]WANG Tao,ZHANG Zhen-xiang,XU Yong-jian.Effect of mitochondrial KATP channel on voltage-gated K+ channel in 24 hour-hypoxic human pulmonary artery smooth muscle cells[J].2005,(1).
- [3]M O, Hengartner.The biochemistry of apoptosis.[J].2000,407(6805).
- [4]J, Yang,X, Liu,K, Bhalla,etc.Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked.[J].1997,275.
- [5]Heber D,Chen SS,Ikezoe T,etc.Oridonin induces growth inhibition and apoptosis of a variety of human cancer cells.[J].2003,23(4).
- [6]Hopkins TeresaA,Puttagunta Lakshmi,Wu XiChen,etc.Dichloroacetate, a metabolic modulator, prevents and reverses chronic hypoxic pulmonary hypertension in rats: role of increased expression and activity of voltage-gated potassium channels.[J].2002,105(2).
- [7]Huang W,Fung YC,Yuan JX,etc.Cellular and molecular mechanisms of pulmonary vascular remodeling: role in the development of pulmonary hypertension.[J].2004,68(2).
- [8]S A, Susin,H K, Lorenzo,N, Zamzami,etc.Molecular characterization of mitochondrial apoptosis-inducing factor.[J].1999,397(6718).
- [9]Bonnet S,Bonnet S,Altieri DC,etc.Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension.[J].2005,115(6).
- [10]Du Y,Villeneuve NF,Li J,etc.Oridonin confers protection against arsenic-induced toxicity through activation of the Nrf2-mediated defensive response.[J].2008,116(9).
- [11]Richard Cooper,Jalal Ghali,Brian E. Simmons,etc.Elevated Pulmonary Artery Pressure: An Independent Predictor of Mortality[J].1991,99(1).
- [12]Dreschers S,Gulbins E,Bock J.Role of mitochondria in apoptosis.[J].2003,88(Pt.1).
- [13]Puig PE,Brunet M,Kroemer G,etc.Mechanisms of cytochrome c release from mitochondria.[J].2006,13(9).
- [14]Li XX,Thompson CB,Schumacker PT,etc.Outer mitochondrial membrane permeability can regulate coupled respiration and cell survival.[J].2000,97(9).
- [15]S H, Kaufmann,W C, Earnshaw.Induction of apoptosis by cancer chemotherapy.[J].2000,256(1).
- [16]A, Gross,J M, McDonnell,S J, Korsmeyer.BCL-2 family members and the mitochondria in apoptosis.[J].1999,13.
- [17]K, Fuji,M, Node,M, Sai,etc.Terpenoids. LIII. Antitumor activity of trichorabdals and related compounds.[J].1989,37(6).
- [18]Martinalbo J,Grubb D,Borner C,etc.Conformational control of Bax localization and apoptotic activity by Pro168.[J].2004,164(7).
- [19]Crompton M.The mitochondrial permeability transition pore and its role in cell death.[J].1999,341(Pt.2).
- [20]Stojanovic M,Marcellus RC,Shore GC,etc.Caspase cleavage product of BAP31 induces mitochondrial fission through endoplasmic reticulum calcium signals, enhancing cytochrome c release to the cytosol.[J].2003,160(7).
- [21]Fujita Tetsuro,Takeda Yoshio,Han-dong Sun,etc.Cytotoxic and Antitumor Activities of Rabdosia Diterpenoids[J].1988.
- [22]Reed JC,Deveraux Q,Jurgensmeier JM,etc.Bax directly induces release of cytochrome c from isolated mitochondria.[J].1998,95(9).
- [23]Solange Desagher,Jean-Claude Martinou.Mitochondria as the central control point of apoptosis[J].2000,10(9).